Target intelligence / Profile preview

Semliki Forest virus non-structural protein 4 (nsP4) (SFV nsP4)

Target
SFV nsP4
Molecular classification
Enzyme, RNA-dependent RNA polymerase, Transferase
01

Overview

Semliki Forest virus non-structural protein 4 (nsP4) is the primary catalytic subunit of the viral replication complex, serving as the RNA-dependent RNA polymerase (RdRp) (UniProt P03315). It is essential for the synthesis of both the negative-strand RNA template and the subsequent positive-strand genomic and subgenomic RNAs required for viral progeny production (Rubach et al., 2009). Because RdRps are unique to viruses and lack direct functional homologs in human cells, nsP4 is a critical target for the development of broad-spectrum antiviral therapies. Drugs such as favipiravir and ribavirin act as nucleoside analogs that are incorporated into the growing RNA chain by nsP4, resulting in chain termination or lethal mutagenesis (Delang et al., 2014). Research into SFV nsP4 also serves as a model for understanding the replication of other medically significant alphaviruses, including Chikungunya and Eastern Equine Encephalitis viruses. The protein contains highly conserved motifs common to all RdRps, making it a focal point for structural biology and drug discovery efforts (Tomar et al., 2006).

Other names
RNA-directed RNA polymeraseRdRpP600nsP4 polymerase
02

Mechanism of action

Inhibition of RNA-dependent RNA polymerase activity through competitive inhibition or chain termination, leading to the suppression of viral RNA synthesis.

03

Biological functions

Viral RNA replicationRNA polymerizationTranscription of subgenomic RNA
04

Disease associations

InfectionSemliki Forest virus infectionAlphavirus infection
05

Safety considerations

Potential for viral resistance mutationsMitochondrial toxicity of nucleoside analogsTeratogenicity associated with certain nucleoside analogs
06

Interacting drugs

Favipiravir

3 more in the full profile.

07

Biomarkers

Viral RNA titernsP4 protein levels

Beyond the preview

Go deeper on Semliki Forest virus non-structural protein 4 (nsP4) (SFV nsP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Semliki Forest virus non-structural protein 4 (nsP4) (SFV nsP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call